Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology/Urology

Clinical Trials: Kidney Cancer


A listing of clinical trials currently looking for volunteers to enroll in Kidney Cancer studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Various Cities : Research Center

Tuberous Sclerosis (Kidney Lesions) Study - M2302

Arizona

Various Cities : Research Center

Tuberous Sclerosis (Kidney Lesions) Study - M2302

Arkansas

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

California

Duarte : City of Hope Updated

A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients with CD70- Positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma

Duarte : City of Hope Updated

A Phase II Study of Pazopanib in VEGF-TKI Refractory Metastatic Renal Cell Carcinoma (MRCC)

Duarte : City of Hope Updated

A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors

Duarte : City of Hope Updated

Development of a Blood Test of Anti-IMP3 Autoantibody for the Detection of Renal Cell Carcinoma with Metastasis and Metastatic Potential

Duarte : City of Hope Updated New

Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors

Duarte : City of Hope Updated New

Phase I/II Study of Dalteparin, a Low Molecular Weight Heparin (LMWH), in Combination with Sunitinib (SU11248), an Oral, Selective Multi-Targeted Tyrosine Kinase Inhibitor, as First Line Treatment, in Patients with Metastatic Renal Cell Carcinoma

Duarte : City of Hope Updated

SWOG S0931: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Encinitas : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Colorado

Denver : The Urology Center of Colorado

Phase II, open-label study evaluating DN24-02 as adjuvant therapy in subjects with high risk HER2+ urothelial carcinoma.

Connecticut

New Haven : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Florida

Various Cities : Research Center

Tuberous Sclerosis (Kidney Lesions) Study - M2302

Georgia

Savannah : Memorial Health University Medical Center

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor AREN 0534

Savannah : Memorial Health University Medical Center

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor COG-AREN0533

Savannah : Memorial Health University Medical Center

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors COG AREN0321

Savannah : Memorial Health University Medical Center

Study of Kidney Tumors in Young Patients COG AREN03B2

Savannah : Memorial Health University Medical Center

Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery ECOG E2805

Savannah : Memorial Health University Medical Center

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor COG AREN0532

Maryland

Bethesda : Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Salisbury : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Massachusetts

Various Cities : Research Center

Tuberous Sclerosis (Kidney Lesions) Study - M2302

View More »

Boston : Beth Israel Deaconess Medical Center

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer

Boston : Beth Israel Deaconess Medical Center

Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer

Michigan

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

Minnesota

Various Cities : Research Center

Tuberous Sclerosis (Kidney Lesions) Study - M2302

Nebraska

Omaha : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Nevada

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

New Jersey

New Brunswick : Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School

Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melanoma Treated on Clinical Trial NCI-06-C-0200

New York

Bronx : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

New York : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

North Carolina

Durham : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Goldsboro : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Ohio

Various Cities : Research Center

Tuberous Sclerosis (Kidney Lesions) Study - M2302

Pennsylvania

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

Tennessee

Nashville : Vanderbilt Univeristy Medical Center

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Texas

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Carcinoma Of The Kidney

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Houston : UT MD Anderson Cancer Center

Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma

Houston : UT MD Anderson Cancer Center

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

Houston : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Houston : UT MD Anderson Cancer Center

Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)

Washington

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

ECOG1808-A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features

Canada

Québec : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Québec : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

France

Limoges Cedex : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Montpellier Cedex 5 : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Villejuif cedex : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Italy

Bologna : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Firenze (FI) : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Milano : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Padova : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Roma : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Poland

Warszawa : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium